Literature DB >> 3139716

Differences in lipopolysaccharide profiles of serologically identical Legionella pneumophila serogroup 6 strains.

O G Zanen-Lim1, H C Zanen.   

Abstract

Over five years 18 strains of Legionella pneumophila serogroup 6 were isolated in Amsterdam from the hot water supply in three hospitals and from one patient. Immunodiffusion and immunoblot procedures showed that these strains were identical. Profiles of isolated lipopolysaccharides from the 18 strains and the reference serogroup 6 strain were visualised in polyacrylamide gels stained with silver. Four strains from hospital A, isolated in 1982, 1984, and 1985 displayed similar lipopolysaccharide profiles which were different in relative mobility from those of hospitals B and C. Those from hospital B (12 strains isolated in 1983 and 1986) and C (one strain) were similar in relative mobility but different in colour. The strain from a patient with acquired immune deficiency syndrome (AIDS) in hospital A displayed a lipopolysaccharide profile characteristic of hospital A. These reproducible profiles were all different in relative mobility from the reference serogroup 6 strain. They can be used as a marker system in epidemiological surveys of serologically identical serogroup 6 strains. Lipopolysaccharide patterns from strains isolated throughout the years in the same hospital were similar. This suggests an outgrowth from organisms inhabiting the plumbing system rather than reseeding from the Amsterdam mains supply.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139716      PMCID: PMC1141610          DOI: 10.1136/jcp.41.8.826

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Legionella pneumophila in a hospital water system following a nosocomial outbreak: prevalence, monoclonal antibody subgrouping and effect of control measures.

Authors:  C D Ribeiro; S H Burge; S R Palmer; J O Tobin; I D Watkins
Journal:  Epidemiol Infect       Date:  1987-06       Impact factor: 2.451

3.  Relationship between colonization of hospital building with Legionella pneumophila and hot water temperatures.

Authors:  J F Plouffe; L R Webster; B Hackman
Journal:  Appl Environ Microbiol       Date:  1983-09       Impact factor: 4.792

4.  Comparison of strains of Legionella pneumophila serogroup 1 isolated in four Amsterdam hospitals from patients and hot-water supplies.

Authors:  O G Zanen-Lim; N J van den Broek; P J Rietra; H C Zanen
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

5.  Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6.

Authors:  M F Para; J F Plouffe
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

6.  Legionella pneumophila serogroup six: isolation from cases of legionellosis, identification by immunofluorescence staining, and immunological response to infection.

Authors:  R M McKinney; H W Wilkinson; H M Sommers; B J Fikes; K R Sasseville; M M Yungbluth; J S Wolf
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

7.  Rapid serological analysis of bacterial lipopolysaccharides by electrotransfer to nitrocellulose.

Authors:  S W Pyle; W B Schill
Journal:  J Immunol Methods       Date:  1985-12-27       Impact factor: 2.303

8.  Serogrouping and subtyping of Legionella pneumophila with monoclonal antibodies.

Authors:  J R Joly; Y Y Chen; D Ramsay
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

9.  Potable water as a source for legionellosis.

Authors:  D W Fraser
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

  9 in total
  1 in total

1.  Cross-reacting lipopolysaccharide antigens in Legionella pneumophila serogroups 1 to 14.

Authors:  D Jürgens; F J Fehrenbach
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.